Cite
Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine.
MLA
Levin, May, et al. “Surmounting Cytarabine-Resistance in Acute Myeloblastic Leukemia Cells and Specimens with a Synergistic Combination of Hydroxyurea and Azidothymidine.” Cell Death & Disease, vol. 10, no. 6, May 2019, p. 390. EBSCOhost, https://doi.org/10.1038/s41419-019-1626-x.
APA
Levin, M., Stark, M., Berman, B., & Assaraf, Y. G. (2019). Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine. Cell Death & Disease, 10(6), 390. https://doi.org/10.1038/s41419-019-1626-x
Chicago
Levin, May, Michal Stark, Bluma Berman, and Yehuda G Assaraf. 2019. “Surmounting Cytarabine-Resistance in Acute Myeloblastic Leukemia Cells and Specimens with a Synergistic Combination of Hydroxyurea and Azidothymidine.” Cell Death & Disease 10 (6): 390. doi:10.1038/s41419-019-1626-x.